Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 13/20 | 0.55 |
| ▸ | PDE4B | Q07343 | 12/20 | 0.55 |
| ▸ | PDE4A | P27815 | 11/20 | 0.55 |
| ▸ | PDE4C | Q08493 | 11/20 | 0.55 |
| ▸ | PPARG | P37231 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | PPARA | Q07869 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4033314 | 0.94 | PDE4D (0.59) | PDE4DPDE4BPDE4APDE4CPTGS2 | |
| SCHEMBL4036023 | 0.92 | PDE4A (0.57) | PDE4DPDE4BPDE4APDE4CPPARG | |
| SCHEMBL4755347 | 0.84 | PDE4D (0.69) | PDE4DPDE4BPDE4APDE4CPPARG | |
| SCHEMBL4032324 | 0.84 | PDE4D (0.69) | PDE4DPDE4BPDE4APDE4CPPARG | |
| SCHEMBL4033553 | 0.83 | SMN1; SMN2 (0.56) | PDE4DPDE4BPDE4APDE4CMAPK1 | |
| SCHEMBL4028222 | 0.83 | MEN1 (0.53) | PPARGCYP3A4MAPK1SMN1; SMN2POLB | |
| SCHEMBL5023283 | 0.82 | PDE4D (0.63) | PDE4DPDE4BPDE4APDE4C | |
| SCHEMBL4030900 | 0.82 | KMT2A (0.57) | SMN1; SMN2POLBPTGS2 | |
| SCHEMBL14364604 | 0.82 | PDE4D (0.49) | PDE4DPDE4BPDE4APDE4CPPARG | |
| SCHEMBL5023369 | 0.82 | PDE4D (0.66) | PDE4DPDE4BPDE4APDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1554262-A1 | NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Glenmark Pharmaceuticals Limited (IN) | 2005-07-20 | — | — | EP | claimed |
| WO-2004037805-A1 | NOVEL TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | GLENMARK PHARMACEUTICALS LTD. (US) | 2004-05-06 | — | — | WO | claimed |